The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension

Clinical Hypertension

Table 9 Target BP in hypertension treatment

Clinical situation	SBP (mmHg)	DBP (mmHg)	COR	LOE
Hypertension without complications
Low to intermediate cardiovascular risk	<140	< 90	I	A
Elderly	<140	< 90	I	A
High cardiovascular risk^a)	< 130	< 80	IIa	B
Diabetes mellitus	< 130	< 80	IIa	B
Low to intermediate risk	< 140	< 90	I	A
High risk^b)	< 130	< 80	IIa	B
Hypertension with complications
Cardiovascular disease^c)	< 130	< 80	IIa	B
Chronic kidney disease
Without albuminuria^d)	<140	< 90	I	A
With albuminuria	< 130	< 80	IIa	B
With diabetes mellitus	< 130	< 80	IIa	B
Stroke	<140	< 90	I	B
Lacunar stroke	< 130	< 80	IIa	B

BP blood pressure, SBP systolic blood pressure, DBP diastolic blood pressure, COR class of recommendation, LOE level of evidence
^a)Subclinical organ damage or cardiovascular risk factors ≥3; ^b)Subclinical organ damage or cardiovascular risk factors ≥1; ^c)Coronary artery disease, peripheral artery disease, abdominal aortic aneurysm, heart failure, or left ventricular hypertrophy; ^d)Microalbuminuria or macroalbuminuria

ISSN: 2056-5909